Page last updated: 2024-10-17

phloroglucinol and Depression, Involutional

phloroglucinol has been researched along with Depression, Involutional in 2 studies

Phloroglucinol: A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.
phloroglucinol : A benzenetriol with hydroxy groups at position 1, 3 and 5.

Depression, Involutional: Form of depression in those MIDDLE AGE with feelings of ANXIETY.

Research Excerpts

ExcerptRelevanceReference
"Hypericum extracts have been regarded as antidepressant drugs without specific side effects by patients, medical professionals and researchers alike."2.42Safety of Hypericum extract in mildly to moderately depressed outpatients: a review based on data from three randomized, placebo-controlled trials. ( Dienel, A; Trautmann-Sponsel, RD, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Trautmann-Sponsel, RD1
Dienel, A1
Vitiello, B1
Shader, RI1
Parker, CB1
Ritz, L1
Harlan, W1
Greenblatt, DJ1
Gadde, KM1
Krishnan, KR1
Davidson, JR1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Placebo Controlled Clinical Trial of a Standardized Extract of Hypericum Perforatum in Major Depressive Disorder[NCT00005013]0 participants Interventional1998-12-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for phloroglucinol and Depression, Involutional

ArticleYear
Safety of Hypericum extract in mildly to moderately depressed outpatients: a review based on data from three randomized, placebo-controlled trials.
    Journal of affective disorders, 2004, Oct-15, Volume: 82, Issue:2

    Topics: Antidepressive Agents; Bridged Bicyclo Compounds; Depressive Disorder, Major; Dose-Response Relation

2004

Trials

1 trial available for phloroglucinol and Depression, Involutional

ArticleYear
Hyperforin plasma level as a marker of treatment adherence in the National Institutes of Health Hypericum Depression Trial.
    Journal of clinical psychopharmacology, 2005, Volume: 25, Issue:3

    Topics: Adult; Biomarkers; Bridged Bicyclo Compounds; Chi-Square Distribution; Depressive Disorder, Major; D

2005